Ghost Tree Capital, LLC Karuna Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $881,600 - $1.2 Million	-5,000 Reduced 28.57%	12,500 $2.71 Million
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $3.63 Million - $4.6 Million	-22,500 Reduced 56.25%	17,500 $3.18 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $1.92 Million - $2.37 Million	10,000 Added 33.33%	40,000 $7.86 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $1.86 Million - $4.16 Million	-15,000 Reduced 33.33%	30,000 $6.75 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $1.41 Million - $2.15 Million	-15,000 Reduced 25.0%	45,000 $5.69 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $5.93 Million - $7.94 Million	60,000 New	60,000 $7.61 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.